Fresenius

U.S. Renal Care Congratulates Sarrah Johnson, DNP, MBA, RN on Power 50 Recognition

Retrieved on: 
Wednesday, March 16, 2022
DEI, Color, Fresenius, MBA, Mentorship, Multimedia, Organization, DNP, DE, District, Senior, Awareness, Kidney disease, Leadership, RN, Woman, CEO, Growth, USRC, Management, Medicine, Operation

PLANO, Texas, March 16, 2022 /PRNewswire/ -- U.S. Renal Care (USRC), a leading provider for people living with kidney disease, is proud to congratulate its Chief Diversity & Inclusion Officer and Senior Vice President of Operations, Sarrah Johnson, DNP, MBA, RN for being named as one of the National Diversity Council's "Power 50" awardees.

Key Points: 
  • The Power 50 honors executive women from top companies who endeavor to improve diversity, equity and inclusion on their teams, within their organizations and across their communities.
  • I'm proud to be recognized and raise awareness of the importance of increasing representation, addressing equity and promoting inclusion.
  • "We are certainly proud of this recognition and are encouraged by the tremendous progress she and her team are pioneering in the kidney care industry."
  • To learn more about the 2022 Power 50 winners, visit Power50.org/2022
    View original content to download multimedia: https://www.prnewswire.com/news-releases/us-renal-care-congratulates-sar...

Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi

Retrieved on: 
Thursday, November 25, 2021
Patient, Trial of the century, Degenerative disease, Saskatchewan River Sturgeon Management Board, Face, BAD, Mentorship, ESPEN, Fresenius (company), Supervisory board, Education, JumpStart, Program, Professor, Metabolism, Critical care, Fresenius, Parenteral nutrition, Research, Transfusion medicine, Collection, Berlin, European Society for Clinical Nutrition and Metabolism, Supervision, Congress, Pharmaceutical industry

BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant on September 10, 2021.

Key Points: 
  • BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant on September 10, 2021.
  • The grant is awarded to help to advance novel, community-led research in parenteral nutrition, to make a difference for critically ill patients.
  • Dr. Jos Simons, Executive Vice President at Fresenius Kabi, commented: "We are absolutely delighted to be able to award this research grant to Professor Schaller.
  • With the JUMPstart education program and research grant, Fresenius Kabi supports the next generation of clinical experts who will contribute to advancement in nutrition therapy in critically ill patients.

Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi

Retrieved on: 
Thursday, November 25, 2021
Patient, Trial of the century, Degenerative disease, Saskatchewan River Sturgeon Management Board, Face, BAD, Mentorship, ESPEN, Fresenius (company), Supervisory board, Education, JumpStart, Program, Professor, Metabolism, Critical care, Fresenius, Parenteral nutrition, Research, Transfusion medicine, Collection, Berlin, European Society for Clinical Nutrition and Metabolism, Supervision, Congress, Pharmaceutical industry

BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant on September 10, 2021.

Key Points: 
  • BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant on September 10, 2021.
  • The grant is awarded to help to advance novel, community-led research in parenteral nutrition, to make a difference for critically ill patients.
  • Dr. Jos Simons, Executive Vice President at Fresenius Kabi, commented: "We are absolutely delighted to be able to award this research grant to Professor Schaller.
  • With the JUMPstart education program and research grant, Fresenius Kabi supports the next generation of clinical experts who will contribute to advancement in nutrition therapy in critically ill patients.

Omnicell and Fresenius Kabi Collaborate to Enhance Management of Controlled Substances in U.S. Hospitals

Retrieved on: 
Wednesday, November 10, 2021
Health, Technology, Hospitals, Software, Pharmaceutical, Hardware, Fresenius (company), Health, OMCL, Safety, Efficiency, Hydromorphone, Pharmacy, Intelligence, Population, CSD, Industry, Observational study, Private Securities Litigation Reform Act, Form 10-K, Medicine, U.S. Securities and Exchange Commission, Technology, Automation, Fentanyl, Syringe, Software, Forward-looking statement, LLC, Risk, Workflow, Annual report, Approximation error, Point, Product management, Hospital, Marketing, Prescription, Fresenius, Solution, Nursing, Time, Morphine, Patient safety, Nasdaq, Substance-related disorder, United Kingdom, Pharmaceutical industry, Fresenius Kabi, Omnicell, FRESENIUS KABI, OMNICELL

The new Fresenius Kabi cassettes for the Omnicell CSD are available now.

Key Points: 
  • The new Fresenius Kabi cassettes for the Omnicell CSD are available now.
  • Fresenius Kabi Simplist MicroVault prefilled syringes are used by hospitals in the United States in an effort to help reduce the amount of time nurses spend preparing doses and documenting waste.
  • Fresenius Kabi is committed to medication safety and the responsible use of controlled substances, said Angie Lindsey, Vice President of Marketing for Fresenius Kabi USA.
  • OMNICELL is a registered trademark and the Omnicell logo is a trademark of Omnicell, Inc. SIMPLIST AND MICROVAULT are registered trademarks of Fresenius Kabi USA, LLC.

VergeSense Raises $60 Million in Series C to Accelerate Development and Innovation in Workplace Analytics

Retrieved on: 
Tuesday, November 9, 2021
Scale Venture Partners, Bill.com, Partner, Culture, SAN, Eye, CEO, DocuSign, Growth, Investment, Program, Bolt, Fresenius, ARR, Workplace, The Redstone Acceleration & Innovation Network, WalkMe, HubSpot, Video game, Management

This investment will help the company accelerate platform innovation and growth as the market increasingly requires data and insights to drive necessary workplace transformation.

Key Points: 
  • This investment will help the company accelerate platform innovation and growth as the market increasingly requires data and insights to drive necessary workplace transformation.
  • Click to Tweet : @VergeSense Raises $60 Million in Series C for Accelerated Innovation of its Workplace Analytics Platform: https://ctt.ac/2C94d+ #proptech #futureofwork
    With 74% of enterprise companies returning to the office adopting a hybrid work model, business leaders are lookingfor new ways to maximize office space investments that foster employee productivity, culture and collaboration.
  • About VergeSense VergeSense is a Workplace Analytics Platform trusted by enterprises across the globe.
  • Today VergeSense analyzes over 40 million square feet and supports customers across 29 countries, including 26 of the Fortune 500.

Hemodialysis Catheters and Dialyzers | Global Markets, Leading Companies, Market Shares, Unit Volumes & Pricing 2020-2025 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 11, 2021
Medical Devices, Health, Fresenius, COVID-19, Medtronic, Catheter, Medical device

The "Global Hemodialysis Catheters and Dialyzers Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Hemodialysis Catheters and Dialyzers Market" report has been added to ResearchAndMarkets.com's offering.
  • This report provides the latest market data for the Global Hemodialysis Catheters and Dialyzers Market.
  • Information covered by this report includes:
    COVID-19 also impacted leading competitors, such as Baxter, B. Braun, Medtronic, Fresenius, Medcomp, and others.
  • The report provides insights into trends, drivers, and limiters of the hemodialysis catheters and dialyzers market, as well as highlights potential opportunities.

Cap Rates For Net Lease Sector Reach New All-Time Lows

Retrieved on: 
Saturday, October 2, 2021
Research, Ways and means committee, United States House Ways and Means Subcommittee on Trade, Treasury, CoStar Group, AutoZone, American Families Plan, 7-Eleven, Fresenius, Senior, Property management, Real estate

Cap rates in the single tenant net lease sector reached a new historic low for all three asset classes in the third quarter of 2021.

Key Points: 
  • Cap rates in the single tenant net lease sector reached a new historic low for all three asset classes in the third quarter of 2021.
  • "Significant investor demand combined with limited supply of quality net lease assets remains the primary driver of continued cap rate compression in the sector" says Randy Blankstein, President, The Boulder Group.
  • As pricing within the net lease sector remains at all-time highs; owners are taking advantage and adding properties to the market.
  • Transaction activity in the net lease sector is expected to remain active throughout 2021 and continue through 2022.

Global Renal Care Management Growth Opportunities Report 2021: Enhancing Remote Management Capabilities for Rapid Expansion of Peritoneal and Home Hemodialysis - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 29, 2021
Medical Devices, Health, Heart failure, Kidney disease, Adoption, ESKD, Solution, Chronic kidney disease, Ageing, Statistics, Cancer, Patient, Population, Dialysis, Fresenius, Hypertension, Kidney, Diabetes, Specialization, Technology, CKD, Comorbidity, Diaverum, Council for Affordable Quality Healthcare, Pharmaceutical industry

The "Global Renal Care Management Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Renal Care Management Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and mental ill health.
  • Renal care management has been expanding from the stage of just caring for End Stage Renal Disease (ESKD) patients to prevention of patients from developing chronic kidney diseases.
  • Renal care solution providers understand the importance of managing associated comorbid conditions and are, therefore, offering collaborative solutions that target these conditions.

Global Home Healthcare Markets to 2027: Custodial Care, Domiciliary Care, & Non-medical Care - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 9, 2021
Health, Medical Supplies, Medical Devices

Home care is the supportive care like custodial care, domiciliary care, or non-medical care which provided at home by registered nurses (RNs), occupation therapists, physical therapists, and licensed practical nurses.

Key Points: 
  • Home care is the supportive care like custodial care, domiciliary care, or non-medical care which provided at home by registered nurses (RNs), occupation therapists, physical therapists, and licensed practical nurses.
  • Home healthcare is classified into various types such as Hospice, and Social Care.
  • Furthermore, increase in government initiatives and technological advancement will have the positive impact on global home healthcare market growth.
  • Moreover, increase in geriatric population is expected to propel the global home healthcare market growth.

Fresenius Kabi and AABB Celebrate 16th Annual Blood Collectors Week

Retrieved on: 
Sunday, September 5, 2021
Biotechnology, Health, Science, Other Science, Medical Supplies, Blood, Transfusion medicine, Medical specialties, Body fluids, Hematology, Blood transfusion, AABB, Fresenius, Blood donation, Transfusion

Fresenius Kabi and AABB announced that today begins the celebration of the 16th annual Blood Collectors Week (Sunday, September 5 through Saturday, September 11, 2021).

Key Points: 
  • Fresenius Kabi and AABB announced that today begins the celebration of the 16th annual Blood Collectors Week (Sunday, September 5 through Saturday, September 11, 2021).
  • During Blood Collectors Week, more than 290 blood centers across the U.S. are expected to host celebrations honoring local collectors.
  • Together with AABB, Fresenius Kabi is honored to recognize the work blood collectors do every day to ensure lifesaving blood components are available to patients in need, said Dean Gregory, President, Global Commercial Operations, Transfusion Medicine and Cell Therapies at Fresenius Kabi USA.
  • AABB is pleased to continue our partnership with Fresenius Kabi to celebrate Blood Collectors Week and honor the work of blood collectors worldwide, said Debra BenAvram, FASAE, CAE, CEO of AABB.